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Introduction: Trichophyton mentagrophytes and T. interdigitale are important causative
agents of superficial mycoses, demonstrating emergent antifungal drug resistance. We stu-
died the antifungal susceptibility profiles in Iranian isolates of these two species.
Methods: A total of 96 T. interdigitale and 45 T. mentagrophytes isolates were subjected to
molecular typing by ribosomal ITS region. Antifungal susceptibility profiles for terbinafine,
griseofulvin, clotrimazole, efinaconazole, luliconazole, amorolfine and ciclopirox were
obtained by CLSI broth microdilution method. The squalene epoxidase (SQLE) gene was
subjected to sequencing for mutations, if any, in isolates exhibiting elevated MICs for
terbinafine.
Results: Luliconazole and efinaconazole showed the lowest MIC values against
T. mentagrophytes and T. interdigitale isolates. There were five isolates with terbinafine
MICs ≥32 µg/mL in our sample. They belonged to T. mentagrophytes type VIII and harbored
two alternative SQLE gene sequence variants, leading to Phe397Leu and Ala448Thr or
Leu393Ser and Ala448Thr substitutions in the enzyme. All terbinafine resistant strains
could be inhibited by luliconazole and efinaconazole.
Conclusion: This study documented a step in the global spread of resistance mechanisms in
T. mentagrophytes. However, treatment alternatives for resistant isolates were available.
Keywords: Trichophyton mentagrophytes, SQLE, terbinafine, antifungal drug resistance,
Iran
Introduction
Dermatophytosis or tinea is known as the most common superficial mycosis in
dermatological practice. It involves skin, nails and hair. Dermatophytosis is caused
by a group of fungi, called dermatophytes. The dermatophytes are cosmopolitan
and encompass more than 50 species from the genera Trichophyton, Microsporum,
Epidermophyton, Arthroderma, Nannizzia, Lophophyton, and Paraphyton.1 Most
skin infections by dermatophytes, especially by Trichophyton spp., are successfully
treated by using terbinafine (TRB), an allylamine compound which is the first-line
oral medication for the treatment of such infections.2 The drug blocks the formation
of ergosterol, the major component of fungal membrane, by inhibiting squalene
epoxidase enzyme (SQLE) and subsequently inhibits the fungal growth.3 However,
an increasing number of difficultly treated cases is being documented.4,5 This
phenomenon can be connected in part with relapses because of poor adherence to
antifungal treatment regime.6 However, the most important part is emergence of
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recalcitrant dermatophytosis due to verified in vivo/in vitro
resistance to TRB.7,8 In the first decade of the 21st century,
terbinafine resistance in dermatophytes was found to be
rare and primarily limited to T. rubrum isolates.9,10
Nonetheless, recent reports from India and some other
Asian and European countries indicate that clinical/micro-
bial TRB resistance now involves T. interdigitale and
T. mentagrophytes.5,11-19 Since these fungi are essentially
conspecific,20 they can be treated together as the
T. mentagrophytes/T. interdigitale species group
(TMTISG).21 In most mentioned reports, clinical therapeu-
tic failures have been correlated with nonsynonymous
point mutations in the SQLE gene. But, there has been
no report on TRB resistance and molecular mechanisms
underlying reduced susceptibility to this antifungal agent
in Iranian TMTISG isolates.
Our study aimed to assess antifungal susceptibility of
Iranian TMTISG isolates. We described five
T. mentagrophytes strains, harboring some known point
mutations in SQLE gene, which probably were responsible
for high terbinafine MICs and proposed treatment alterna-
tives for TRB resistant cases.
Materials and Methods
Clinical Isolates
A total of 141 clinical TMTISG isolates from different
provinces of Iran were included in the study. These iso-
lates were a part of a recent investigation on the epide-
miological aspects of infections due to the TMTISG in
Iran over a two-year study during 2016–2018.21 The study
was approved by the Ethic Committee of Ahvaz
Jundishapur University of Medical Sciences, Ahvaz, Iran
(approval ID: IR.AJUMS.REC.1398.851).
Molecular Identification of the Isolates
Identification of all isolates was performed by sequencing
of the internal transcribed spacer region of ribosomal DNA
(ITS). Briefly, the isolates were sub-cultured on Sabouraud
dextrose agar (SDA; BD Diagnostics, USA) and incubated
at 28°C for one week. Genomic DNA was isolated from
the mycelium of each strain by mechanical homogeniza-
tion in lysis buffer, consisting of 200 mM Tris-HCl [pH
8.0], 0.5% sodium dodecyl sulfate, 250 mM NaCl, and 25
mM EDTA22 with the use of SpeedMill device (Analytik
Jena, Germany), followed by purification with phenol-
chloroform-isoamyl alcohol (25:24:1) and precipitation
with ethanol. ITS region was amplified in each isolate by
V9G (5′-TTACGTCCCTGCCCTTTGTA-3′) and LS266
(5′-GCATTCCCAAACAACTCGACTC-3′) primers.23
The amplification program could be schematically repre-
sented in the following way: 6 min 94°C; 35 × [30 s 94°C,
30 s 58°C, 1 min 72°C]; 10 min 72°C. The amplified
products were sequenced with the use of mentioned pri-
mers and the BigDye Terminator Kit version 3.1 (Applied
Biosystems, USA), in an ABI Prism 3130XL Genetic
Analyzer (Applied Biosystems, USA). The obtained raw
sequences were imported to MEGA software ver. 7.024
and quality-checked. Each isolate was identified down to
the species level by BLAST search of respective ITS
sequence against annotated sequences, deposited in the
Westerdijk Fungal Biodiversity Institute (CBS) database
(http://www.cbs.knaw.nl).
Antifungal Susceptibility Testing
In vitro AFST against TMTISG isolates was done by the
Clinical and Laboratory Standards Institute broth microdilu-
tion method, according to CLSI M38-A2 document.25 The
following drugs were tested: terbinafine (TRB; Combi-
Blocks, USA), itraconazole (ITC; Sigma-Aldrich, USA),
griseofulvin (GRE; Wako Pure Chemical, Japan), clotrima-
zole (CLT; Sigma-Aldrich, USA), efinaconazole (EFN;
Nihon Nohyaku, Japan), luliconazole (LUZ; Funakoshi,
Japan), amorolfine hydrochloride (AHC; LKT Laboratories,
USA) and ciclopirox olamine (CPO; LKT Laboratories,
USA). The final concentration of each antifungal agent was
as follows: 0.001–0.5 µg/mL for TRB, 0.016–8 µg/mL for
ITC, 0.015–8 µg/mL for GRE, 0.0625–32 µg/mL for CLT,
0.001 to 0.5 µg/mL for EFN, 0.00006–0.031 µg/mL for LUZ,
0.03–16 µg/mL for AHC and 0.004–2 µg/mL for CPO. To
promote conidiation, we cultured the strains for a week at 28°
C on Petri dishes containing modified Sabouraud Glucose
agar, diluted 10-fold (peptone 0.2%, KH2PO4 0.1%, MgSO4
·7H2O 0.1%, glucose 0.1%, agar 1.5%).
26 The sterile saline
containing 0.05% (w/v) Tween 80 was added to the surface
of each mature colony and inoculum suspension was pre-
pared by rubbing with a sterile scraper. Conidial suspension
was harvested by a sterile syringe and transferred to a sterile
filter (0.4 µm) to eliminate the hyphal masses. After gentle
shaking conidial suspension was diluted to achieve 65–70%
light transmission at wavelength of 530 nm. To obtain final
density of 1 × 103 to 3 × 103 CFU/mL, the conidial suspen-
sion was diluted in RPMI 1640 medium, with the ratio of
1:50. For each isolate, the dermatophyte-free and antifungal-
free controls were used and microplates were incubated at
30°C. To check the performance accuracy of AFST, the CLSI
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reference strains of Candida parapsilosis ATCC 22019 and
C. krusei ATCC 6258 were used as control for every new
batch of tested isolates. The minimal inhibitory concentra-
tions (MICs) for all used antifungals were defined as the
lowest concentration that led to complete inhibition of obser-
vable growth after 96 hrs.
Sequencing of Squalene Epoxidase (SQLE)
Gene and Analysis
In order to determine whether a mutation in the SQLE
gene could be potentially involved in elevated TRB
MICs, the partial SQLE gene in five resistant isolates,
and also in five susceptible isolates for comparison, was
amplified and sequenced with the TrSQLE-F1 (5’-
ATGGTTGTAGAGGCTCCTCCC-3’) and TrSQLE-R1
(5’-CTAGCTTTGAAGTTCGGCAAA-3’) primer pair.11
A PCR machine was run according to a program, modified
from Singh et al: 5 min 95°C; 34 × [30 s 95°C, 30 s 60°C,
3 min 72°C]; 10 min 72°C.5 The predicted amino acid
sequences of SQLE in all tested T. mentagrophytes isolates
were compared with the reference sequence for
T. mentagrophytes and T. interdigitale (GenBank accession
number KU242352).
ITS Typing
Given that some recent reports correlated in vitro/in vivo
TRB resistance in the TMTISG with a distinct ITS geno-
type (Type VIII), the nucleotide sequences for ribosomal
ITS1-5.8S-ITS2 region in all isolates were used for typing
by a script (https://github.com/Ivan-Pchelin/genotyping-by
-sequencing). All point mutations and indel events strictly
within the borders of ITS region were considered
significant.21
Results
By ITS sequencing, 96 isolates were identified as
T. interdigitale and 45 isolates as T. mentagrophytes. The
T. interdigitale isolates originated from tinea pedis (n = 71),
tinea unguium (n = 20) and tinea corporis (n = 5) infections,
while the majority of T. mentagrophytes isolates were from
tinea corporis (n = 43), followed by tinea capitis (n = 1) and
nail infection (n = 1).
Table 1 summarizes MIC ranges, geometric means
(GMs) of MICs, and the MIC50/MIC90 ratios of 8 antifungal
drugs used against 141 TMTISG isolates. GMMIC values of
LUZ and EFN against T. interdigitale isolates were 0.0016
and 0.0057 μg/mL while these values for T. mentagrophytes
isolates were 0.0024 and 0.009 μg/mL, respectively.Whereas
GRE had the highest GM MIC value (1.1 μg/mL) for
T. interdigitale isolates, CLT showed the highest GM MIC
value (3.25 μg/mL) against T. mentagrophytes isolates. In
view of susceptibility to TRB, all T. interdigitale isolates
were susceptible to this agent (MICs range = 0.003–0.25
µg/mL and MIC90 = 0.0125 µg/mL) while the MICs of
TRB for T. mentagrophytes isolates were in the range
0.007-≥32 µg/mL. We found 5 T. mentagrophytes isolates
with TRB MICs ≥32 µg/mL (resistant). From a total of 45
T. mentagrophytes isolates, 28 isolates harbored ITS type
VIII and all five TRB resistant strains were from this geno-
type (5/28; 18%).
The partial SQLE sequence was successfully amplified
in all 5 sensitive and 5 resistant strains. The obtained
sequences were deposited in GenBank under accession
numbers MN893286 and MN901902–MN901905 for sus-
ceptible and MN901906–MN901910 for resistant strains.
All T. mentagrophytes resistant isolates harbored missense
mutations in SQLE, corresponding to amino acid substitu-
tion Ala448Thr in combination with Leu393Ser (isolate
Table 1 MIC Values (μg/mL) of 8 Antifungal Agents Against 141 Trichophyton interdigitale and T. mentagrophytes Isolates
Species Antifungal
MICs
TRB ITC EFN LUZ CLT AHC CPO GRE
T. interdigitale (n=96) MICGM 0.038 0.36 0.0057 0.0016 1.43 0.92 0.45 1.1
MIC50 0.062 0.5 0.007 0.003 1 1 0.5 1
MIC90 0.125 1 0.015 0.001 4 2 1 2
MIC range 0.003–0.25 0.062–8 0.001–0.125 0.0004–0.015 0.25–16 0.125–4 0.062–1 0.062–4
T. mentagrophytes
(n=45)
MICGM 0.12 0.32 0.009 0.0024 3.25 0.92 0.56 1.8
MIC50 0.625 0.25 0.0075 0.003 4 1 0.5 2
MIC90 >32 0.5 0.031 0.001 16 2 1 4
MIC range 0.007–>32 0.062–2 0.001–0.125 0.0004–0.015 0.5–32 0.125–4 0.062–1 0.25–4
Abbreviations: TRB, terbinafine; ITC, itraconazole; EFN, efinaconazole; LUZ, luliconazole; CLT, clotrimazole; AHC, amorolfine hydrochloride; CPO, ciclopirox olamine;
GRE, griseofulvin.
Dovepress Taghipour et al
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R1) or Phe397Leu (isolates R2 to R5). On the other hand,
two susceptible isolates (MICs = 0.125–0.25 µg/mL)
revealed wild type SQLE sequence, while the three other
isolates (MICs = 0.0075–0.25 µg/mL) showed a single
Ala448Thr substitution (Table 2).
Discussion
The antifungal susceptibility profile of Iranian TMTISG iso-
lates, described in our results (Table 1), was comparable to
that ones from other Iranian and foreign studies.12,27-30 The
MIC values of EFN against TMTISG isolates from Japan,
Canada, US and Iran in three studies all in all ranged from
0.001 to 0.03 µg/mL.27–29 They did not differ significantly
from the MIC values for EFN in the current study (MICs =
0.001–0.125 µg/mL). Similarly, LUZ inhibitory concentra-
tions against our TMTISG isolates ranged from 0.0004 to
0.015 µg/mL and were comparable with 0.0001–0.004 µg/
mL for this imidazole against TMTISG strains in two previous
reports from US and Iran.28,29 In two other investigations,
LUZ has also had the most pronounced in vitro effect against
TMTISG isolates from India and Iran, when compared with
other antifungals, though theMIC values were higher (0.016–-
0.25 µg/mL) than in the current study.12,30 In our assessment,
AHC and CPO in comparison with other novel antifungals,
such as LUZ and EFN, demonstrated lower activities against
TMTISG isolates (Table 1). The GM MIC value for CPO
against T. interdigitale (0.45 µg/mL) in the present study, was
similar to those found by Rudramurthy et al12 (0.25 µg/mL)
and Magagnin et al (0.6 µg/mL).31 In the present study, the
MIC90 for AHC against TMTISG isolates was 2 μg/mL,
which was not compatible with those reported for
T. interdigitale (0.02 μg/mL) and T. mentagrophytes (0.125
μg/mL) in India and US.12,28 In agreement with the reports by
Singh et al and Baghi et al, TMTISG strains showed increased
susceptibility to CLT and GRE.5,30 In our study, all
T. mentagrophytes isolates with high MICs for terbinafine
(≥32 µg/mL) and point mutations in the SQLE gene, were
inhibited by 0.015 μg/mL of LUZ and 0.125 μg/mL of EFN.
Given that there are no reports on dermatophyte resistance to
newly FDA approved antifungals EFN and LUZ, these agents
should be taken into consideration in the cases of TRB resis-
tance as alternatives.
To the extent of our knowledge, TRB resistance in
TMTISG isolates has already been reported from at least
eight Asian and European countries, including India,5,12,14,15
Switzerland,11,16 Japan,13 Finland,17 Denmark,18 Bahrain,19
Russia,32 and Germany.19 The TRB MIC values in resistant
TMTISG isolates from Iran and other countries varied in the
range≥1–≥32 μg/mL.12–14,16–18 In the current report, similar to
some other studies,5,15,17,19 all TRB resistant isolates belonged
to T. mentagrophytes species and ITS type VIII (5/28; 18%).
Despite this, careful analysis of the literature revealed resistant
Type II strains (Table 3).Hence,more data are needed to clarify
whether in the TMTISG there is an association between geno-
types and a potential to develop antifungal drug resistance.
Among amino acid substitutions in SQLE, leading to TRB
resistance, the most commonly encountered are Phe397Leu
and Leu393Phe (Tables 2 and 3). The substitution Leu393Ser
or other less common substitutions were also correlated with
a highMIC value (≥32 μg/mL) of TRB. In some cases, in vitro
resistance could not be explained by the presence of any
mutation in SQLE (wild type).12,13 Then, mechanisms other
than Phe397Leu and Leu393Phe substitution should still be
considered as alternatives for TRB treatment failure. For exam-
ple, Santos et al, recently showed that TRB resistance in
T. rubrum can be mediated by multiplication of salicylate
1-monooxygenase (salA) gene.33
Conclusion
Overall, in both T. mentagrophytes and T. interdigitale, the
potencies of LUZ and EFN against TMTISG isolates were
apparently greater than those of other agents. Here, for the
first time in Iran, we described TRB resistance in TMTISG
isolates with its molecular mechanisms. The emergence of
high level of in vitro TRB resistance with proven mutation in
Table 2 MIC Values (μg/mL) of Used Antifungal Agents Against
10 Terbinafine Resistant/Susceptible T. mentagrophytes Isolates
and Corresponding GenBank Accession with Consequential
Amino Acid Substitutions in SQLE Gene
Resistant Sensitive
SQLE accession number MN901906–
MN901910
MN901902–MN901905,
MN893286
Amino Acid Substitution
Phe397Leu/Ala448Thr 4 0
Leu393Ser/ Ala448Thr 1 0
Ala448Thr 0 3
Wild type 0 2
MIC Values (μg/mL)
TRB ≥32 0.125–0.25
ITC 0.125–2 0.25–2
EFN 0.002–0.008 0.008–0.125
LUZ 0.008–0.004 0.008–0.015
CLT 1–8 2–16
AHC 0.5–2 0.25–4
CPO 0.5–1 0.5–1
GRE 1–4 1–4
Taghipour et al Dovepress
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SQLE gene in Iranian T. mentagrophytes isolates is unpro-
mising and warrants the genotyping of isolates primarily
resistant to TRB.
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